Lataa...
First use of tofacitinib to treat an immune checkpoint inhibitor-induced arthritis
Immune checkpoint inhibitors have revolutionised cancer treatment; however, immune-related adverse events do occur, with up to 7% developing inflammatory arthritis. Common rheumatoid arthritis therapies such as methotrexate, prednisolone and biologics have been used to treat this arthritis in small,...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868229/ https://ncbi.nlm.nih.gov/pubmed/33541985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-238851 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|